Expression of splice variants of 1α-hydroxylase in mcf-7 breast cancer cells

被引:11
|
作者
Cordes, T. [1 ]
Diesing, D. [1 ]
Becker, S. [1 ]
Fischer, D. [1 ]
Diedrich, K. [1 ]
Friedrich, M. [1 ]
机构
[1] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde & Gebursthilfe, D-23538 Lubeck, Germany
来源
关键词
vitamin D; breast cancer; MCF-7; 1; alpha-hydroxylase; splice variants;
D O I
10.1016/j.jsbmb.2006.12.034
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
1,25-Dihydroxyvitamin D-3 (calcitriol) is the most active natural metabolite of Vitamin D-3. It has strong antiproliferative and differentiating effects on various cell types including breast cancer cells. 25-Hydroxyvitamin D-3-1 alpha-hydroxylase (1 alpha-hydroxylase, CYP27B1) is one of the key enzymes in the formation of calcitriol. It has been found in breast cancer cells suggesting an autocrine regulation of formation of calcitriol in these cells. Alternative splicing of the encoding genes for this enzyme can possibly play a role in regulating the enzyme level and can explain tissue specific variations of 1 alpha-hydroxylase activity. Splice variants containing intron I may encode for truncated proteins with deletion of protein domains which are essential for its enzymatic activity. In order to obtain more information on the abundance of 1 alpha-hydroxylase splice variants, we performed a highly specific nested touchdown PCR in MCF-7 cells. The full-length sequence of 1 alpha-hydroxylase and two different splice variants of this enzyme containing intron I were isolated. By Western blot technique we then confirmed the protein products of the full-length enzyme and its splice variants. We hypothesize that that the expression of splice variants can lead to a quantitatively lower expression of the mRNA of the full-length enzyme. The abundance of less active 1 alpha-hydroxylase protein variants can alter the local synthesis of calcitriol in the cells and may explain variations of enzymatic activity in different cells and tissues. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:326 / 329
页数:4
相关论文
共 50 条
  • [1] Expression of adenosine receptors in MCF-7 human breast cancer cells
    Clark, JH
    Broadley, KJ
    Hutcheson, IR
    Nicholson, RI
    Kidd, EJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U65 - U65
  • [2] Estrogen receptor messenger RNA splice variants are not involved in antiestrogen resistance in sublines of MCF-7 human breast cancer cells
    Madsen, MW
    Reiter, BE
    Larsen, SS
    Briand, P
    Lykkesfeldt, AE
    CANCER RESEARCH, 1997, 57 (04) : 585 - 589
  • [3] OTUB1 expression and interaction network analyses in MCF-7 breast cancer cells
    Iskandar, Athirah
    Zulkifli, Nur Wahida
    Ahmad, Muhammad Khairi
    Das, Kumitaa Theva
    Zulkifle, Nurulisa
    GENE REPORTS, 2021, 24
  • [4] Inhibition of MP1 expression induces apoptosis of MCF-7 breast cancer cells
    Marina, Mihaela
    Conrad, Susan E.
    FASEB JOURNAL, 2011, 25
  • [5] Expression and regulation of alkaline phosphatases in human breast cancer MCF-7 cells
    Tsai, LC
    Hung, MW
    Chen, YH
    Su, WC
    Chang, GG
    Chang, TC
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (05): : 1330 - 1339
  • [6] Prolidase in human breast cancer MCF-7 cells
    Palka, JA
    Phang, JM
    CANCER LETTERS, 1998, 127 (1-2) : 63 - 70
  • [7] Comparison of the properties of human breast cancer cells: MCF-7 and MCF-7 cells selected for resistance to etoposide
    Cory, AH
    Cory, JG
    ADVANCES IN ENZYME REGULATION, VOL 41, 2001, 41 : 177 - 188
  • [8] MCF-7 as a Model for Functional Analysis of Breast Cancer Risk Variants
    Booms, Alix
    Coetzee, Gerhard A.
    Pierce, Steven E.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2019, 28 (10) : 1735 - 1745
  • [9] Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin
    Plonka-Czerw, Justyna
    Zyrek, Luiza
    Latocha, Malgorzata
    MOLECULES, 2024, 29 (15):
  • [10] Effect of adriamycin on BRCA1 and PARP-1 expression in MCF-7 breast cancer cells
    Wang, Hui
    Lu, Changqing
    Tan, Yan
    Xie, Jun
    Jiang, Jingting
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5909 - 5915